Protara Therapeutics Inc (TARA) returns
Protara Therapeutics returns over 10 years
$1,000 invested in Protara Therapeutics ten years ago was worth $6.28 at the close on October 30, 2026, with dividends reinvested: an average return of -39.8% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -18.7% | — | $813.12 | -0.9% |
| 3 months | -38.5% | — | $615.39 | +2.1% |
| Year to date | -53.5% | — | $465.29 | +11.7% |
| 1 year | -51.8% | — | $482.49 | +12.4% |
| 3 years | +105.0% | +27.0% | $2,050 | +88.5% |
| 5 years | -64.2% | -18.6% | $358.38 | +76.0% |
| 10 years | -99.4% | -39.8% | $6.28 | +316.6% |
Protara Therapeutics return by calendar year
| Year | TARA | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -53.5% | +11.7% | -65.2% |
| 2025 | +0.9% | +17.7% | -16.8% |
| 2024 | +181.6% | +24.9% | +156.7% |
| 2023 | -30.0% | +26.2% | -56.2% |
| 2022 | -60.3% | -18.2% | -42.1% |
| 2021 | -72.1% | +28.7% | -100.9% |
| 2020 | +47.6% | +18.4% | +29.2% |
| 2019 | -81.9% | +31.2% | -113.2% |
| 2018 | +19.5% | -4.6% | +24.0% |
| 2017 | 0.0% | +21.7% | -21.7% |
| 2016 | -87.7% | +12.0% | -99.8% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Protara Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.